Quest Diagnostics (DGX)
(Real Time Quote from BATS)
$152.60 USD
-1.38 (-0.90%)
Updated Sep 24, 2024 11:48 AM ET
2-Buy of 5 2
B Value C Growth C Momentum B VGM
Income Statements
Fiscal Year end for Quest Diagnostics Incorporated falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 9,252 | 9,883 | 10,788 | 9,437 | 7,726 |
Cost Of Goods | 6,199 | 6,450 | 6,579 | 5,804 | 5,037 |
Gross Profit | 3,053 | 3,433 | 4,209 | 3,633 | 2,689 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,791 | 2,005 | 1,828 | 1,662 | 1,458 |
Income After Depreciation & Amortization | 1,262 | 1,428 | 2,381 | 1,971 | 1,231 |
Non-Operating Income | 20 | -55 | 369 | 76 | 20 |
Interest Expense | 152 | 138 | 151 | 163 | 175 |
Pretax Income | 1,130 | 1,235 | 2,599 | 1,884 | 1,076 |
Income Taxes | 248 | 264 | 597 | 460 | 247 |
Minority Interest | 54 | 69 | 85 | 68 | 48 |
Investment Gains/Losses | 26 | 44 | 78 | 75 | 57 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 908 | 1,015 | 2,080 | 1,499 | 886 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 20 |
Net Income (GAAP) | 854 | 946 | 1,995 | 1,431 | 858 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,701 | 1,865 | 2,789 | 2,332 | 1,560 |
Depreciation & Amortization (Cash Flow) | 439 | 437 | 408 | 361 | 329 |
Income After Depreciation & Amortization | 1,262 | 1,428 | 2,381 | 1,971 | 1,231 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 113.00 | 118.00 | 128.00 | 136.00 | 136.00 |
Diluted EPS Before Non-Recurring Items | 8.71 | 9.95 | 14.24 | 11.18 | 6.56 |
Diluted Net EPS (GAAP) | 7.49 | 7.97 | 15.55 | 10.47 | 6.28 |
Fiscal Year end for Quest Diagnostics Incorporated falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 2,397.00 | 2,366.00 | 2,288.00 | 2,295.00 | 2,338.00 |
Cost Of Goods | 1,593.00 | 1,595.00 | 1,552.00 | 1,541.00 | 1,546.00 |
Gross Profit | 804.00 | 771.00 | 736.00 | 754.00 | 792.00 |
SG&A, R&D, and Dept/Amort Expenses | 449.00 | 471.00 | 469.00 | 412.00 | 444.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 355.00 | 300.00 | 267.00 | 342.00 | 348.00 |
Non-Operating Income | 3.00 | 9.00 | 10.00 | -3.00 | 6.00 |
Interest Expense | 44.00 | 43.00 | 40.00 | 40.00 | 37.00 |
Pretax Income | 314.00 | 266.00 | 237.00 | 299.00 | 317.00 |
Income Taxes | 74.00 | 66.00 | 40.00 | 68.00 | 75.00 |
Minority Interest | 11.00 | 14.00 | 13.00 | 12.00 | 14.00 |
Investment Gains/Losses | 0.00 | 8.00 | 8.00 | 6.00 | 7.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 240.00 | 208.00 | 205.00 | 237.00 | 249.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 229.00 | 194.00 | 192.00 | 225.00 | 235.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 112.00 | 112.00 | 113.00 | 114.00 | 114.00 |
Diluted EPS Before Non-Recurring Items | 2.35 | 2.04 | 2.15 | 2.22 | 2.30 |
Diluted Net EPS (GAAP) | 2.03 | 1.72 | 1.70 | 1.96 | 2.05 |